Drug intelligence / Profile preview

Effaclar

Development stage
Unknown
Lead developer
La Roche-Posay
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

Effaclar is a brand name for a range of over-the-counter and prescription-strength topical acne treatments developed by La Roche-Posay. The main active pharmaceutical ingredient in some Effaclar products is adapalene (a synthetic retinoid), which works by regulating skin cell turnover to prevent clogged pores and reduce acne lesions. Other formulations under the Effaclar brand include salicylic acid (a keratolytic agent that helps shed dead skin cells and reduce inflammation) and benzoyl peroxide (an antibacterial agent that reduces Propionibacterium acnes on the skin). These products are primarily indicated for mild to moderate acne vulgaris[1][2][3][4][7][8].

Brand names
EffaclarEffaclar Adapalene Gel 0.1%Effaclar DuoEffaclar Clarifying Solution
Other names
adapalenesalicylic acid topicalbenzoyl peroxide topical
02

Targets

RARB (Retinoic acid receptor beta)RARG (Retinoic acid receptor gamma)TA (Teichoic acid)RAR (Retinoic acid receptor)

Beyond the preview

Go deeper on Effaclar.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Effaclar.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call